84 results
8-K
EX-99.1
RVNC
Revance Therapeutics Inc
9 May 24
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
4:08pm
standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance’s portfolio … share; the potential to set a new standard in healthcare; patient outcomes and physician experiences; development of an onobotulinumtoxinA biosimilar
8-K
EX-99.2
RVNC
Revance Therapeutics Inc
9 May 24
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
4:08pm
60,000 people in the United States.
About Revance
Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic … to set a new standard in healthcare; development of an onobotulinumtoxinA biosimilar with our partner, Viatris; and commercialization of DAXXIFY®
424B5
RVNC
Revance Therapeutics Inc
5 Mar 24
Prospectus supplement for primary offering
5:00pm
to set a new standard in healthcare;
our ability to build and expand valuable aesthetic and therapeutic franchises;
the wind down of all activities
424B5
r4jf5te8hs3aas7tql
4 Mar 24
Prospectus supplement for primary offering
6:39am
8-K
EX-99.1
s76hjq
28 Feb 24
Provides Corporate Update
4:07pm
8-K
EX-99.1
447dvsq
8 Jan 24
Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
8:01am
8-K
EX-99.1
rhln20zno4
8 Nov 23
Provides Corporate Update
4:09pm
8-K
EX-99.1
omj2xmj3 pmasf2k
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
EX-99.2
kiit5fwairoberst
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
EX-99.1
11jzlpntnl8ietv 6199
8 Aug 23
Provides Corporate Update
4:08pm
8-K
EX-99.1
o57ov7xebn ck226o2
9 May 23
Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update
4:07pm
8-K
EX-99.1
onehts bf7hlf399
8 Nov 22
Provides Corporate Update
4:06pm